RICCHETTI INCORPORATED for NOVARTIS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| Year-End Report (this page) | Jan 24, 2008 | $120,000 | Replaced |
| Year-End Amendment | Jul 7, 2009 | $120,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Issues related to the Patent Reform Act (S. 1145, HR 1908)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE ALBEE | N/A |
| JEFF RICCHETTI | N/A |
| STEVE RICCHETTI | N/A |
Health Issues HCR
Issues relating to use of thimarisol in vaccines Issues related to the PDUFA reauthorization Issues related to drug importation (Prescription Drug Affordability Act, H.R. 194, Pharmaceutical Market Access and Safety Drug Act, S. 242, H.R. 380) Issues related to financing of vaccine infrastructure and drug pricing in DOD Authorization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE ALBEE | N/A |
| JEFF RICCHETTI | N/A |
| STEVE RICCHETTI | N/A |
Medicare/Medicaid MMM
Issues related to CHAMP (Children's Health and Medicare Protection Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE ALBEE | N/A |
| JEFF RICCHETTI | N/A |
| STEVE RICCHETTI | N/A |
Advertising ADV
Issues relating to direct-to-consumer marketing of prescription drugs (FDA Amendments Act, HR 2900, S. 1082)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE ALBEE | N/A |
| JEFF RICCHETTI | N/A |
| STEVE RICCHETTI | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.